These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2244537)

  • 1. Antioxidant and prooxidant effects of the antipsoriatic compound anthralin in skin and subcellular fractions.
    Fuchs J; Nitschmann W; Packer L
    Adv Exp Med Biol; 1990; 264():537-41. PubMed ID: 2244537
    [No Abstract]   [Full Text] [Related]  

  • 2. Antipsoriatic and proinflammatory action of anthralin. Implications for the role of oxygen radicals.
    Müller K
    Biochem Pharmacol; 1997 May; 53(9):1215-21. PubMed ID: 9214681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anthralin. Different concentration effects on epidermal cell DNA synthesis rates in mice and clinical responses in human psoriasis.
    Lowe NJ; Breeding J
    Arch Dermatol; 1981 Nov; 117(11):698-700. PubMed ID: 7316528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An EPR method for estimating activity of antioxidants in mouse skin using an anthralin-derived radical model.
    Kawai S; Matsumoto K; Utsumi H
    Free Radic Res; 2010 Mar; 44(3):267-74. PubMed ID: 20001648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigations of anthralin free radicals in model systems and in skin of hairless mice.
    Fuchs J; Packer L
    J Invest Dermatol; 1989 May; 92(5):677-82. PubMed ID: 2541207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsoriatic drug action of anthralin: oxidation reactions with peroxidizing lipids.
    Ducret F; Lambelet P; Löliger J; Savoy MC
    J Free Radic Biol Med; 1985; 1(4):301-6. PubMed ID: 3836247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antipsoriatic compound anthralin influences bioenergetic parameters and redox properties of energy transducing membranes.
    Fuchs J; Nitschmann WH; Packer L
    J Invest Dermatol; 1990 Jan; 94(1):71-6. PubMed ID: 2104916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo detection of anthralin-derived free radicals in the skin of hairless mice by low-frequency electron paramagnetic resonance spectroscopy.
    Mäder K; Bacic G; Swartz HM
    J Invest Dermatol; 1995 Apr; 104(4):514-7. PubMed ID: 7706769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free radicals in skin exposed to dithranol and its derivatives.
    Shroot B; Brown C
    Arzneimittelforschung; 1986 Aug; 36(8):1253-5. PubMed ID: 3022762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a therapeutic concentration of dithranol in the mouse-tail test.
    Hofbauer M; Dowd PM; Atkinson J; Whitefield M; Greaves MW
    Br J Dermatol; 1988 Jan; 118(1):85-9. PubMed ID: 3342179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of free radicals in the mode of action of anthralin.
    Lambelet P; Löliger J; Shroot B
    Skin Pharmacol; 1988; 1(2):115-21. PubMed ID: 2856181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsoriatic anthrones: aspects of oxygen radical formation, challenges and prospects.
    Müller K
    Gen Pharmacol; 1996 Dec; 27(8):1325-35. PubMed ID: 9304402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ingram method: the precursor of photochemotherapy.
    Raab WP
    Br J Dermatol; 1981 Aug; 105 Suppl 20():77-81. PubMed ID: 7284273
    [No Abstract]   [Full Text] [Related]  

  • 14. Inactivation of mouse epidermal 12-lipoxygenase by anthralin--implications for the role of oxygen radicals.
    Müller K; Gawlik I
    Biochem Pharmacol; 1996 May; 51(9):1173-9. PubMed ID: 8645340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anthralin derivatives--inhibition of 5-lipoxygenase--antipsoriatic efficacy.
    Tanzer H; Braun C; Seidel M; Wiegrebe W
    Arch Pharm (Weinheim); 1991 Nov; 324(11):841-6. PubMed ID: 1804060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Disappearance of psoriactic lesions under the effect of anthralin].
    Chowaniec O
    Przegl Dermatol; 1976; 63(5):665-71. PubMed ID: 1005760
    [No Abstract]   [Full Text] [Related]  

  • 17. Antioxidants attenuate anthralin-induced skin inflammation in BALB/c mice: role of specific proinflammatory cytokines.
    Lange RW; Germolec DR; Foley JF; Luster MI
    J Leukoc Biol; 1998 Aug; 64(2):170-6. PubMed ID: 9715255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsoriatic drug anthralin induces EGF receptor phosphorylation in keratinocytes: requirement for H(2)O(2) generation.
    Peus D; Beyerle A; Vasa M; Pott M; Meves A; Pittelkow MR
    Exp Dermatol; 2004 Feb; 13(2):78-85. PubMed ID: 15009100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anthralin inhibits elevated levels of thioredoxin reductase in psoriasis. A new mode of action for this drug.
    Schallreuter KU; Pittelkow MR
    Arch Dermatol; 1987 Nov; 123(11):1494-8. PubMed ID: 2445297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calmodulin inhibition by anthralin? Investigations in vitro and in vivo.
    Wollina U; Klinger R; Wetzker R; Knopf B
    Dermatologica; 1989; 179(2):61-3. PubMed ID: 2529149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.